Back to Search
Start Over
Stimuli-responsive injectable chitosan-based hydrogels for controlled drug delivery systems.
- Source :
-
Frontiers in bioengineering and biotechnology [Front Bioeng Biotechnol] 2023 Jan 06; Vol. 10, pp. 1126774. Date of Electronic Publication: 2023 Jan 06 (Print Publication: 2022). - Publication Year :
- 2023
-
Abstract
- In the last decade, injectable hydrogels have attracted a lot of attention due to their excellent functional properties in the field of drug delivery for precise, non-invasive and focused tissue locations. Therefore, designing drug delivery systems (DDS) responsive to hydrogel stimuli to release a drug to an external stimulus with various advantages, can be very challenging. Due to their biocompatibility, mucosal adhesion, and hemostatic activity, chitosan (Chitosan)-based hydrogels offer a lot of potential for tissue engineering and drug delivery. It can be difficult to manage the structure of these stimuli-responsive CS hydrogels or they may require additional crosslinking agents, such as hydrogels with dual pH and thermo-responsiveness. Therefore, it is crucial to create these hydrogels for medicinal applications.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2023 Garshasbi, Salehi, Naghib, Ghorbanzadeh and Zhang.)
Details
- Language :
- English
- ISSN :
- 2296-4185
- Volume :
- 10
- Database :
- MEDLINE
- Journal :
- Frontiers in bioengineering and biotechnology
- Publication Type :
- Academic Journal
- Accession number :
- 36698640
- Full Text :
- https://doi.org/10.3389/fbioe.2022.1126774